These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31171114)

  • 1. Predictors and Outcomes of Renal Replacement Therapy After Left Ventricular Assist Device Implantation.
    Asleh R; Schettle S; Briasoulis A; Killian JM; Stulak JM; Pereira NL; Kushwaha SS; Maltais S; Dunlay SM
    Mayo Clin Proc; 2019 Jun; 94(6):1003-1014. PubMed ID: 31171114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative Proteinuria and Reduced Glomerular Filtration Rate Predicts Renal Replacement Therapy in Patients Supported With Continuous-Flow Left Ventricular Assist Devices.
    Topkara VK; Coromilas EJ; Garan AR; Li RC; Castagna F; Jennings DL; Yuzefpolskaya M; Takeda K; Takayama H; Sladen RN; Mancini DM; Naka Y; Radhakrishnan J; Colombo PC
    Circ Heart Fail; 2016 Dec; 9(12):. PubMed ID: 27932533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of renal replacement therapy in patients with continuous flow left ventricular assist devices.
    Parikh U; Lamba H; Ajmal M; Vincent J; Walther C; Shafii A; Nair A; Civitello A; Liao K; Chatterjee S
    J Artif Organs; 2021 Jun; 24(2):207-216. PubMed ID: 33598826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-operative proteinuria in left ventricular assist devices and clinical outcome.
    Muslem R; Caliskan K; Akin S; Sharma K; Gilotra NA; Brugts JJ; Houston B; Whitman G; Tedford RJ; Hesselink DA; Bogers AJJC; Manintveld OC; Russell SD
    J Heart Lung Transplant; 2018 Jan; 37(1):124-130. PubMed ID: 28781011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in renal function after implantation of continuous-flow left ventricular assist devices.
    Hasin T; Topilsky Y; Schirger JA; Li Z; Zhao Y; Boilson BA; Clavell AL; Rodeheffer RJ; Frantz RP; Edwards BS; Pereira NL; Joyce L; Daly R; Park SJ; Kushwaha SS
    J Am Coll Cardiol; 2012 Jan; 59(1):26-36. PubMed ID: 22192665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative renal dysfunction does not affect outcomes of left ventricular assist device implantation.
    Kilic A; Chen CW; Gaffey AC; Wald JW; Acker MA; Atluri P
    J Thorac Cardiovasc Surg; 2018 Sep; 156(3):1093-1101.e1. PubMed ID: 30017440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of acute kidney injury after left ventricular assist device implantation: Evaluation of clinical risk scores.
    Pilarczyk K; Carstens H; Papathanasiou M; Luedike P; Koch A; Jakob H; Kamler M; Pizanis N
    Artif Organs; 2020 Feb; 44(2):162-173. PubMed ID: 31361341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors and Clinical Outcomes of Vasoplegia in Patients Bridged to Heart Transplantation With Continuous-Flow Left Ventricular Assist Devices.
    Asleh R; Alnsasra H; Daly RC; Schettle SD; Briasoulis A; Taher R; Dunlay SM; Stulak JM; Behfar A; Pereira NL; Frantz RP; Edwards BS; Clavell AL; Kushwaha SS
    J Am Heart Assoc; 2019 Nov; 8(22):e013108. PubMed ID: 31701791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular assist device implantation may be feasible in appropriately selected patients with severe renal insufficiency.
    Pasrija C; Tran D; George P; Sorensen E; Kaczorowski DJ; Ton VK; Kon ZN;
    J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1307-1319.e2. PubMed ID: 31128896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic Kidney Disease and Acute Kidney Injury Outcomes Post Left Ventricular Assist Device Implant.
    Ajmal MS; Parikh UM; Lamba H; Walther C
    Cureus; 2020 Apr; 12(4):e7725. PubMed ID: 32432003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative Right-Sided Cardiac Congestion Is Associated with Gastrointestinal Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices.
    Tomizawa Y; Tanaka A; Kitahara H; Sakuraba A; Uriel N; Jeevanandam V; Ota T
    Dig Dis Sci; 2018 Jun; 63(6):1518-1524. PubMed ID: 29417325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early versus standard renal replacement therapy after left ventricular assist device implantation.
    Liu H; Jeng E; Demos D; Vilaro J; Ahmed MM; Parker A; Pinzon J; Aranda J; Beaver TM; Arnaoutakis GJ
    J Card Surg; 2020 Oct; 35(10):2529-2538. PubMed ID: 32741013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device Implantation.
    Kassis H; Cherukuri K; Agarwal R; Kanwar M; Elapavaluru S; Sokos GG; Moraca RJ; Bailey SH; Murali S; Benza RL; Raina A
    JACC Heart Fail; 2017 Feb; 5(2):81-88. PubMed ID: 28017353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal risk stratification in left ventricular assist device therapy.
    Givens RC; Topkara VK
    Expert Rev Med Devices; 2018 Jan; 15(1):27-33. PubMed ID: 29252053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystatin C- Versus Creatinine-Based Assessment of Renal Function and Prediction of Early Outcomes Among Patients With a Left Ventricular Assist Device.
    Pinsino A; Mondellini GM; Royzman EA; Hoffman KL; D'Angelo D; Mabasa M; Gaudig A; Zuver AM; Masoumi A; Garan AR; Mohan S; Husain SA; Toma K; Faillace RT; Giles JT; Takeda K; Takayama H; Naka Y; Topkara VK; Demmer RT; Radhakrishnan J; Colombo PC; Yuzefpolskaya M
    Circ Heart Fail; 2020 Jan; 13(1):e006326. PubMed ID: 31959016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Echocardiographic predictors of adverse outcomes after continuous left ventricular assist device implantation.
    Topilsky Y; Oh JK; Shah DK; Boilson BA; Schirger JA; Kushwaha SS; Pereira NL; Park SJ
    JACC Cardiovasc Imaging; 2011 Mar; 4(3):211-22. PubMed ID: 21414567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Right ventricular response to pulsatile load is associated with early right heart failure and mortality after left ventricular assist device.
    Grandin EW; Zamani P; Mazurek JA; Troutman GS; Birati EY; Vorovich E; Chirinos JA; Tedford RJ; Margulies KB; Atluri P; Rame JE
    J Heart Lung Transplant; 2017 Jan; 36(1):97-105. PubMed ID: 27469015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of age on outcomes following continuous-flow left ventricular assist device implantation.
    Lushaj EB; Badami A; Osaki S; Murray M; Leverson G; Lozonschi L; Akhter S; Kohmoto T
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The aspartate transaminase/alanine transaminase (DeRitis) ratio predicts mid-term mortality and renal and respiratory dysfunction after left ventricular assist device implantation.
    Pilarczyk K; Carstens H; Heckmann J; Canbay A; Koch A; Pizanis N; Jakob H; Kamler M
    Eur J Cardiothorac Surg; 2017 Oct; 52(4):781-788. PubMed ID: 29156019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Right Ventricular Assist Device Use in Patients Undergoing Continuous-Flow Left Ventricular Assist Device Implantation: Incidence and Risk Factors From the Interagency Registry for Mechanically Assisted Circulatory Support.
    Kiernan MS; Grandin EW; Brinkley M; Kapur NK; Pham DT; Ruthazer R; Rame JE; Atluri P; Birati EY; Oliveira GH; Pagani FD; Kirklin JK; Naftel D; Kormos RL; Teuteberg JJ; DeNofrio D
    Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29021348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.